D-0239-2026 Class II Ongoing
FDA drug recall D-0239-2026 was initiated by Preferred Pharmaceuticals, Inc. on Nov 17, 2025 and is designated Class II. Reason for recall: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals… The recall status is ongoing. Affected quantity: 575 1x10 Foil Blister Packs.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 24, 2025
- Initiation Date
- Nov 17, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 575 1x10 Foil Blister Packs
Product Description
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Reason for Recall
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Distribution Pattern
Natinowide in the USA
Code Information
Lot: J1325J, I1725P, EXP Date: 4/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0239-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026